Longitudinal studies of putative growth hormone (GH) biomarkers and hematological and steroidal parameters in relation to 2 weeks administration of human recombinant GH-Reference-Cited by-同舟云学术

Longitudinal studies of putative growth hormone (GH) biomarkers and hematological and steroidal parameters in relation to 2 weeks administration of human recombinant GH

Published:2020-03-13 Issue:6 Volume:12 Page:711-719
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test Anal

Author:

Sieckmann Tobias¹,Elmongy Hatem²,Ericsson Magnus¹³,Bhuiyan Hasanuzzaman²,Lehtihet Mikael⁴,Ekström Lena¹^ORCID

Affiliation:

1. Department of Laboratory Medicine, Division of Clinical PharmacologyKarolinska Institutet Stockholm Sweden

2. Department of Environmental Science and Analytical ChemistryStockholm University Stockholm Sweden

3. Doping Control Laboratory, Department of Clinical PharmacologyKarolinska University Hospital, Stockholm, Sweden

4. Department of MedicineKarolinska Institutet Stockholm Sweden

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.2787

Reference29 articles.

1. High-Sensitivity Chemiluminescence Immunoassays for Detection of Growth Hormone Doping in Sports

2. The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays

3. Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets

4. Human growth hormone doping in sport

5. Report on an anti‐doping operation in Guadeloupe: High number of positive cases and inferences about doping habits

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker ratios;Drug Testing and Analysis;2022-03-20

2. Red blood cell derived extracellular vesicles during the process of autologous blood doping;Drug Testing and Analysis;2021-09-10

3. Metabolomic signatures in elite cyclists: differential characterization of a seeming normal endocrine status regarding three serum hormones;Metabolomics;2021-07

4. Coupling Complete Blood Count and Steroidomics to Track Low Doses Administration of Recombinant Growth Hormone: An Anti-Doping Perspective;Frontiers in Molecular Biosciences;2021-06-10

5. Establishment of a post‐race biomarkers database and application of pathway analysis to identify potential biomarkers in post‐race equine plasma;Drug Testing and Analysis;2021-05-17